ArticleACS omega2026
Deep Eutectic Solvents as Designer Phase-Change Materials for Organic Rankine Cycle Applications.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organic Rankine cycles (ORCs) are one of the most prominent technologies for efficient energy use, from renewable or residual energy sources. These systems are widely used due to their simple design and flexibility. One interesting addition to an ORC is a thermal energy accumulator (TEA), which can improve the energy utilization efficiency. This contribution analyzes the thermal and exergetic efficiency changes when a TEA is added to an ORC. Seven novel deep eutectic solvent (DES)-based phase-change materials (PCMs) are studied and compared with paraffin wax used as a benchmark compound. The ORC uses ten different working fluids (WF), including fluorinated gases and hydrocarbons (HCs). The results show that R1233zd and
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.